OX40 costimulation can abrogate Foxp3+regulatory T cell-mediated suppression of antitumor immunity
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference48 articles.
1. Control of immune pathology by regulatory T cells;Mason;Curr Opin Immunol,1998
2. Regulatory T cells in the control of immune pathology;Maloy;Nat Immunol,2001
3. CD4+ regulatory T cells in autoimmunity and allergy;Curotto de Lafaille;Curr Opin Immunol,2002
4. Natural versus adaptive regulatory T cells;Bluestone;Nat Rev Immunol,2003
5. Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR;Valzasina;Blood,2005
Cited by 68 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients;International Immunopharmacology;2024-08
2. Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model;BIOMED ENVIRON SCI;2024
3. Engineered immunomodulatory extracellular vesicles derived from epithelial cells acquire capacity for positive and negative T cell co-stimulation in cancer and autoimmunity;2023-11-04
4. Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies;Cancer;2023-10-21
5. Regulating the regulatory T cells as cell therapies in autoimmunity and cancer;Frontiers in Medicine;2023-09-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3